What is the role of 5-azacytidine in cancer treatment?

What is the role of 5-azacytidine in cancer treatment?

What is the role of 5-azacytidine in cancer treatment?

5-AZA-CdR can reactivate tumor suppressor genes silenced by aberrant DNA methylation, a frequent event in all types of cancer. Because this epigenetic change is reversible, it is a good target for 5-AZA-CdR therapy.

How does 5-azacytidine affect gene expression?

5-azacytidine (5-azaC) is used as an experimental tool for demethylation and it induces differentiation in various systems. In the chick embryo, the first cellular migrations signal the onset of primitive streak and gastrula formation and result in neural induction and morphogenesis of the embryonic axis.

How do you dissolve 5-azacytidine?

5-Azacytidine is supplied as a crystalline solid. A stock solution may be made by dissolving the 5-azacytidine in the solvent of choice, which should be purged with an inert gas. 5-Azacytidine is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide.

What are the side effects of azacitidine?

Azacitidine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • nausea.
  • vomiting.
  • diarrhea.
  • constipation.
  • sores on the mouth or tongue.
  • hemorrhoids.
  • stomach pain or tenderness.
  • heartburn.

What is the nadir for Vidaza?

The following side effects are common (occurring in greater than 30%) for patients taking azacitadine: Low blood counts (low white blood cells, platelets, and red blood cells) Nadir: meaning low point, nadir is the point in time between chemotherapy cycles in which you experience low blood counts. Nadir: 10-17 days.

How long can you stay on azacitidine?

We strongly recommend that patients be treated with azacitidine for a minimum of 6 months, and that in patients who achieve a documented response or stable disease (sd), treatment be continued until disease progression or unacceptable toxicity occurs.

Can azacitidine cure MDS?

Azacitidine is a chemotherapy drug, however, it is a “hypomethylating agent”. Hypomethylating agents are considered a non-intensive treatment. They are aimed at slowing the progression of the disease with as few side effects as possible, maintaining a good quality of life. They will not cure MDS but may ‘modify’ it.